Detalhe da pesquisa
1.
Daridorexant for the treatment of insomnia disorder: findings and implications.
Eur J Clin Pharmacol
; 78(11): 1749-1761, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36098753
2.
Use of medicinal plants during COVID-19 pandemic in Brazil.
Sci Rep
; 13(1): 16558, 2023 10 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37783716
3.
Self-Medication during the COVID-19 Pandemic in Brazil: Findings and Implications to Promote the Rational Use of Medicines.
Int J Environ Res Public Health
; 20(12)2023 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37372730
4.
TransCon human growth hormone for children with growth hormone deficiency: a technology evaluation.
Expert Opin Drug Deliv
; 19(1): 1-7, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34996331
5.
Small molecule CGRP receptor antagonists for the preventive treatment of migraine: A review.
Eur J Pharmacol
; 922: 174902, 2022 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35358493
6.
Abdeg technology for the treatment of myasthenia gravis: efgartigimod drug experience.
Expert Rev Clin Immunol
; 18(9): 879-888, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35892247
7.
Economic evaluation of adalimumab versus etanercept for psoriatic arthritis in a Brazilian real-world model.
Expert Rev Pharmacoecon Outcomes Res
; 22(3): 473-479, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33474995
8.
Conventional Synthetic Disease-Modifying Anti-rheumatic Drugs for Psoriatic Arthritis: Findings and Implications From a Patient Centered Longitudinal Study in Brazil.
Front Pharmacol
; 13: 878972, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35559237
9.
Cost-utility analysis of the anti-TNF therapy for rheumatoid arthritis in a real-world based model.
Expert Rev Pharmacoecon Outcomes Res
; 21(5): 1011-1016, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33086882
10.
FIRST LINE OF SUBCUTANEOUS ANTI-TNF THERAPY FOR RHEUMATOID ARTHRITIS: A PROSPECTIVE COHORT STUDY.
Expert Rev Clin Immunol
; 16(12): 1217-1225, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33203248
11.
Impact of biologic DMARDs on quality of life: 12-month results of a rheumatic diseases cohort using the Brazilian EQ-5D tariff.
Hosp Pract (1995)
; 48(4): 213-222, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32567403
12.
Comparative persistence of anti-tumor necrosis factor therapy in ankylosing spondylitis patients: a multicenter international study.
Curr Med Res Opin
; 36(4): 677-686, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31990224
13.
Biological therapy in the treatment of psoriatic arthritis: economic and epidemiological considerations.
Expert Rev Clin Immunol
; 15(8): 879-887, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31192746
14.
Access to high-cost medications for psoriatic arthritis in the National Health System in Brazil: the long path up to dispensation.
Adv Rheumatol
; 59(1): 48, 2019 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31727164
15.
First line of biological drugs in rheumatoid arthritis: a medication persistence analysis.
Expert Rev Clin Pharmacol
; 12(4): 363-370, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30813823
16.
Effectiveness and safety of anti-TNF in psoriatic arthritis patients in Brazil: a post-incorporation analysis.
J Comp Eff Res
; 7(10): 989-1000, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30277088
17.
Quality of life of patients with Diabetes Mellitus Types 1 and 2 from a referal health centre in Minas Gerais, Brazil.
Expert Rev Clin Pharmacol
; 9(5): 739-46, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26873164